Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to set standards for diagnosing arm artery disease

NCT ID NCT05192707

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study measures oxygen pressure in the skin of the upper arm to help diagnose chronic limb ischemia, a condition where blood flow is severely reduced. Researchers will test 30 healthy volunteers and at least 30 patients with known arm artery disease to find normal values and a threshold for critical ischemia. The goal is to create standardized guidelines for using this non-invasive test in the upper limb.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transcutaneous oxygen pressure (TcPO2) measurement
What this could lead to
If successful, this could establish standard normal values and diagnostic thresholds for upper limb ischemia, improving detection and treatment decisions.
What could go wrong
This is a small, early-stage study with only 39 participants, so results may not apply broadly. It focuses on measurement, not treatment, so direct patient benefit is limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

39 people

The number who actually took part.

Started

Mar 2022

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will be made of : 1. healthy volunteers, 2. and patients with upper limb arterial disease followed in the "Explorations Fonctionnelles Vasculaires" Unit of the "Médecine Interne" department of Edouard Herriot hospital (HCL, Lyon).

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Healthy volunteers part: Inclusion Criteria: * healthy volunteer without upper limb arterial disease * absence of opposition * affiliated to social insurance Exclusion Criteria: * under 18 yrs old * under law protection * pregnancy Retrospective patients part: Inclusion Criteria: * patients with a TCPO2 measurement available for the upper limb * patients with a follow-up of at least 3 months available * absence of opposition * affiliated to social insurance Exclusion Criteria: * under 18 yrs old * under law protection * pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Peripheral arterial diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Service de Médecine Interne - UF Explorations Fonctionnelles Vasculaires, Hôpital Edouard Herriot

    Lyon, Lyon, 69003, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.